Unknown

Dataset Information

0

Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury.


ABSTRACT: The endothelin system may be an important player in hypertensive end-organ injury as endothelin-1 increases blood pressure and is pro-inflammatory. The immune system is emerging as an important regulator of blood pressure and we have shown that the early hypertensive response to angiotensin-II infusion was amplified in mice deficient of myeloid endothelin-B (ETB) receptors (LysM-CreEdnrblox/lox). Hypothesizing that these mice would display enhanced organ injury, we gave angiotensin-II to LysM-CreEdnrblox/lox and littermate controls (Ednrblox/lox) for six weeks. Unexpectedly, LysM-CreEdnrblox/lox mice were significantly protected from organ injury, with less proteinuria, glomerulosclerosis and inflammation of the kidney compared to controls. In the eye, LysM-CreEdnrblox/lox mice had fewer retinal hemorrhages, less microglial activation and less vessel rarefaction. Cardiac remodeling and dysfunction were similar in both groups at week six but LysM-CreEdnrblox/lox mice had better endothelial function. Although blood pressure was initially higher in LysM-CreEdnrblox/lox mice, this was not sustained. A natriuretic switch at about two weeks, due to enhanced ETB signaling in the kidney, induced a hypertensive reversal. By week six, blood pressure was lower in LysM-CreEdnrblox/lox mice than in controls. At six weeks, macrophages from LysM-CreEdnrblox/lox mice were more anti-inflammatory and had greater phagocytic ability compared to the macrophages of Ednrblox/lox mice. Thus, myeloid cell ETB receptor signaling drives this injury both through amplifying hypertension and by inflammatory polarization of macrophages.

SUBMITTER: Guyonnet L 

PROVIDER: S-EPMC7652550 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury.

Guyonnet Léa L   Czopek Alicja A   Farrah Tariq E TE   Baudrie Véronique V   Bonnin Philippe P   Chipont Anna A   Lenoir Olivia O   Sennlaub Florian F   Roubeix Christophe C   Webb David J DJ   Kluth David C DC   Bailey Matthew A MA   Tharaux Pierre-Louis PL   Dhaun Neeraj N  

Kidney international 20200620 5


The endothelin system may be an important player in hypertensive end-organ injury as endothelin-1 increases blood pressure and is pro-inflammatory. The immune system is emerging as an important regulator of blood pressure and we have shown that the early hypertensive response to angiotensin-II infusion was amplified in mice deficient of myeloid endothelin-B (ET<sub>B</sub>) receptors (LysM-CreEdnrblox/lox). Hypothesizing that these mice would display enhanced organ injury, we gave angiotensin-II  ...[more]

Similar Datasets

| S-EPMC1847692 | biostudies-literature
2013-09-05 | E-GEOD-44925 | biostudies-arrayexpress
| S-EPMC8857079 | biostudies-literature
| S-EPMC8806086 | biostudies-literature
| S-EPMC5732736 | biostudies-literature
2013-09-05 | GSE44925 | GEO
2024-05-13 | GSE255281 | GEO
| S-EPMC1489696 | biostudies-literature
| S-EPMC5533228 | biostudies-literature
| S-EPMC6995952 | biostudies-literature